Martin Gliem1, Rolf Fimmers2, Philipp L Müller1, Christian K Brinkmann1, Robert P Finger3, Doris Hendig4, Frank G Holz1, Peter Charbel Issa5. 1. Department of Ophthalmology, University of Bonn, Bonn, Germany. 2. Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany. 3. Department of Ophthalmology, University of Bonn, Bonn, Germany; Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Australia. 4. Institute for Laboratory and Transfusion Medicine, Heart and Diabetes, Center North Rhine-Westphalia, University Hospital of the Ruhr University of Bochum, Bad Oeynhausen, Germany. 5. Department of Ophthalmology, University of Bonn, Bonn, Germany. Electronic address: peter.issa@ukb.uni-bonn.de.
Abstract
PURPOSE: To investigate the impact of Bruch membrane pathology on the choroid in pseudoxanthoma elasticum (PXE). DESIGN: Monocenter cross-sectional prospective case series. METHODS: The study included 61 eyes of 51 patients with PXE and 54 eyes of 54 normal subjects. The diagnosis of PXE was based on skin biopsy, genetic analysis or both. Eyes with PXE were subdivided into 3 groups: eyes without choroidal neovascularization (CNV) or chorioretinal atrophy (Group 1); eyes with active or fibrotic CNV (Group 2); and eyes with chorioretinal atrophy only (Group 3). Choroidal thickness was measured using enhanced-depth imaging optical coherence tomography (EDI-OCT). RESULTS: Compared to controls (331 μm ± 24; mean ± 95% CI), mean subfoveal choroidal thickness in eyes of patients with PXE was significantly reduced within all 3 groups (Group 1: 243 μm ± 29; Group 2: 184 μm ± 28; Group 3: 104 μm ± 28; P < 0.001). Associated structural changes included apparent loss of small choroidal vessels. The difference of PXE compared to control eyes was largest close to the optic disc and approximated the level of controls toward the periphery. Within the PXE subgroups, eyes without CNV or chorioretinal atrophy (Group 1) showed the least reduction of choroidal thickness, while it was most pronounced in Group 3. CONCLUSIONS: The results indicate that changes of Bruch membrane can be associated with choroidal alterations, which are most pronounced in the presence of advanced disease. A role of Bruch membrane in choroidal homeostasis may reflect a possible contribution of Bruch membrane alterations to CNV and geographic atrophy development in age-related macular degeneration.
PURPOSE: To investigate the impact of Bruch membrane pathology on the choroid in pseudoxanthoma elasticum (PXE). DESIGN: Monocenter cross-sectional prospective case series. METHODS: The study included 61 eyes of 51 patients with PXE and 54 eyes of 54 normal subjects. The diagnosis of PXE was based on skin biopsy, genetic analysis or both. Eyes with PXE were subdivided into 3 groups: eyes without choroidal neovascularization (CNV) or chorioretinal atrophy (Group 1); eyes with active or fibrotic CNV (Group 2); and eyes with chorioretinal atrophy only (Group 3). Choroidal thickness was measured using enhanced-depth imaging optical coherence tomography (EDI-OCT). RESULTS: Compared to controls (331 μm ± 24; mean ± 95% CI), mean subfoveal choroidal thickness in eyes of patients with PXE was significantly reduced within all 3 groups (Group 1: 243 μm ± 29; Group 2: 184 μm ± 28; Group 3: 104 μm ± 28; P < 0.001). Associated structural changes included apparent loss of small choroidal vessels. The difference of PXE compared to control eyes was largest close to the optic disc and approximated the level of controls toward the periphery. Within the PXE subgroups, eyes without CNV or chorioretinal atrophy (Group 1) showed the least reduction of choroidal thickness, while it was most pronounced in Group 3. CONCLUSIONS: The results indicate that changes of Bruch membrane can be associated with choroidal alterations, which are most pronounced in the presence of advanced disease. A role of Bruch membrane in choroidal homeostasis may reflect a possible contribution of Bruch membrane alterations to CNV and geographic atrophy development in age-related macular degeneration.
Authors: Sebastian Gorgonius Passon; Viviane Küllmar; Anna Katharina Blatzheim; Kristin Solveig Pausewang; Max Jonathan Stumpf; Doris Hendig; Martin Gliem; Simon Pingel; Robert Schueler; Dirk Skowasch; Najib Schahab; Georg Nickenig; Christian Alexander Schaefer Journal: Intractable Rare Dis Res Date: 2018-02
Authors: Rosa Dolz-Marco; María Andreu-Fenoll; Pablo Hernández-Martínez; M Dolores Pinazo-Durán; Roberto Gallego-Pinazo Journal: Int J Retina Vitreous Date: 2016-06-13
Authors: Kamron N Khan; Shyamanga Borooah; Leonardo Lando; Kunny Dans; Omar A Mahroo; Amit Meshi; Angelos Kalitzeos; Georgios Agorogiannis; Sasan Moghimi; William R Freeman; Andrew R Webster; Anthony T Moore; Martin McKibbin; Michel Michaelides Journal: Transl Vis Sci Technol Date: 2020-05-23 Impact factor: 3.283
Authors: Peter M Maloca; Christian Freichel; Christof Hänsli; Philippe Valmaggia; Philipp L Müller; Sandrine Zweifel; Christine Seeger; Nadja Inglin; Hendrik P N Scholl; Nora Denk Journal: Sci Rep Date: 2022-08-02 Impact factor: 4.996
Authors: Simon Pingel; Sebastian Gorgonius Passon; Kristin Solveig Pausewang; Anna Katharina Blatzheim; Carmen Pizarro; Izabela Tuleta; Martin Gliem; Peter Charbel Issa; Nadjib Schahab; Georg Nickenig; Dirk Skowasch; Christian Alexander Schaefer Journal: PLoS One Date: 2016-09-13 Impact factor: 3.240